Boston Centre of Excellence Open House Event

Join us for an exclusive event at PCI Pharma Services’ Boston Center of Excellence.

Where: 75 Fruit Street Bridgewater, MA, 02324
Where: November 7th, 2023, 10:00 am – 3:00 pm EST.

As we continue our commitment to excellence, we are thrilled to announce our Boston state-of-the-art facility is up and running. Nestled in the heart of New England, this facility stands as a testament to our dedication to serving our clients on the East Coast, providing a robust and secure clinical supply hub.

Join us for a special Open House event where you can explore our cutting-edge facility and meet Chris Hamlin, Anita Pacitti and Shawn Murtough, and PCI’s leading representatives, including a chance to chat directly with our QP and Regulatory subject matter experts.

We will be offering tours of the fully completed facility for the event duration, and lunch and snacks will be available. Also, we’ll be raffling New England Patriots Tickets to those who attend.

Due to a high demand to meet and hear from our QP and Regulatory experts, Shawn Murtough (Director of Quality and Regulatory Services, EU/UK Qualified Person) and Christopher Hamlin (Senior Manager of Regulatory Affairs) will deliver a short presentation highlighting recent changes in the US and EU regulatory landscape and their impacts on the clinical trial supply chain. Sharing experiences and client case studies, they will outline how PCI’s Quality and Regulatory Services (QRS) can support your clinical program through to commercial marketing authorization with bespoke quality and regulatory solutions. 

Presentation Times: 11 am & 1:30 pm

NOTE: If you are interested in hearing from our experts, please sign up immediately, spaces are limited to 25 attendees at each presentation. Once registered for the Open House event, you will receive an email with a link to sign up for the preferred QP/Regulatory presentation time slot.

talkfuture@pci.com

Always growing and continually advancing, we support you from early-stage development through commercialization and beyond, and with 6000+ people in 30 global GMP facilities, we are always near.